← Evidence map

ReviewNeurology and therapy2020

An Evidence-Based Review of Galcanezumab for the Treatment of Migraine.

Ivan Urits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33010021